Over the next 5 years, Scandinavian CRO’s vision is to expand in the Nordic countries and double its workforce. As part of this vision, SCRO has recently strengthened its management team with Erik Olaisson. Erik has more than 30 years of experience working in the pharma industry and is currently Senior Advisor and Business Development Manager at SCRO.
Erik brings to SCRO his extensive strategic and operational experience in product and clinical development within the pharmaceutical and medical device businesses. Erik’s most recent position was at Uppsala BIO (STUNS foundation) working in Business Development.
”Erik has a deep understanding of the industry and a broad expertise, which will be an invaluable resource for both the leadership team and our customers who need support in designing their clinical development strategies,” says Ulrika Hammarström Lüllmaa, CEO.
Erik is thrilled about joining the SCRO team, particularly since there’s a lot happening in the industry right now. “It is a very exciting time for CROs, especially thanks to the high demand of clinical evaluations and clinical validations from MedTech and IVD companies, driven by the implementation of the new MDR and IVDR directives. There are also increasing trends in the development of eHealth products and biological treatments including gene and cell therapies (ATMPs). I strongly believe that companies like Scandinavian CRO, that have an incredible drive and commitment, can deliver exceptional value to our partners in development,” says Erik.
Learn more about the Scandinavian CRO’s management team and advisors.
